MusclePharm(R) Corporation (OTCBB:MSLP), reported that Ron Sekura, B.S., M.S., PhD., will join MusclePharm board of directors as its Director of Therapeutic Research. Dr. Sekura will be assisting in the development of MusclePharm's therapeutic indication and application for patients with HIV experiencing catabolic cachexia. Ron Sekura is currently President of VivoNex LLC and Biotechnology Assessment Services, Inc.

Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufacturers a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. MusclePharm's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com.

GreenHouse Holdings, Inc. (OTCQB:GRHU) previously announced the signing of multiple contract awards for its Life Protection (LPI) Governmental Services Division, totaling $6 million. The recently acquired LPI subsidiary provides innovative training, support, design and construction of facilities and services to meet the needs of the U. S. Government, military, and law enforcement agencies.

GreenHouse Holdings, Inc. provides energy-efficiency products, energy management systems, eco-friendly infrastructure, scalable waste-to-fuel bio-fuel and closed loop systems, as well as other proprietary technologies and products that are utilized to provide a greener and safer future for millions of people.

For more info about this company please visit http://www.greenhouseintl.com/

The Cheesecake Factory Incorporated (NASDAQ:CAKE) recently reported financial results for the third quarter of fiscal 2010, which ended on September 28, 2010.

Total revenues were $418.4 million in the third quarter of fiscal 2010 as compared to $400.6 million in the prior year third quarter. Net income and diluted net income per share were $22.0 million and $0.37, respectively.

The Regions Financial Corporation (NYSE:RF) Board of Directors declared a quarterly cash dividend of 1 cent per common share, payable January 3, 2011, to stockholders of record as of December 17, 2010.

Kindred Healthcare, Inc. (NYSE:KND) will provide an online, real-time webcast of its conference call covering third quarter 2010 operating results on Tuesday, November 2, 2010.

KND will issue its third quarter 2010 earnings release after the close of trading on Monday, November 1, 2010.

Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup

**************************************************************

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB)